BSE Live
Dec 04, 12:25Prev. Close
4977.00
Open Price
4971.85
Bid Price (Qty.)
4988.25 (7)
Offer Price (Qty.)
4996.10 (2)
NSE Live
Dec 04, 12:25Prev. Close
4972.50
Open Price
4972.50
Bid Price (Qty.)
4989.50 (3)
Offer Price (Qty.)
4993.30 (1)
| Cash Flow of Pfizer (in Rs. Cr.) | Nov 08 | Nov 07 | Nov 06 | |
| 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 211.22 | 468.69 | 186.01 | |
| Net CashFlow From Operating Activities | 237.76 | 16.45 | 123.19 | |
| Net Cash Used In Investing Activities | -78.87 | 232.53 | 7.46 | |
| Net Cash Used From Financing Activities | -95.20 | -75.90 | -33.82 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 63.69 | 173.09 | 96.83 | |
| Cash And Cash Equivalents Begin of Year | 479.91 | 306.83 | 210.00 | |
| Cash And Cash Equivalents End Of Year | 543.61 | 479.91 | 306.83 |
18.11.2025
13.11.2025
Pfizer Standalone September 2025 Net Sales at Rs 642.34 crore, up 9.13% Y-o-Y
13.11.2025
03.10.2025
Why Pfizer struck a drug-pricing deal with the Trump administration
13.11.2025
Pfizer Standalone September 2025 Net Sales at Rs 642.34 crore, up 9.13% Y-o-Y
20.05.2025
Pfizer Standalone March 2025 Net Sales at Rs 591.91 crore, up 8.28% Y-o-Y
01.02.2025
Pfizer Standalone December 2024 Net Sales at Rs 537.99 crore, down 0.37% Y-o-Y
30.07.2024
Pfizer Standalone June 2024 Net Sales at Rs 562.86 crore, up 5.93% Y-o-Y
19.10.2016
05.08.2016
03.01.2014
10.01.2011